Pfizer, pocketing a big tax cut from Trump, will end investment in Alzheimer`s and Parkinson`s research
(LA Times NBA)

With every passing day, it becomes clearer who´s reaping the benefit of the huge tax cut handed over to American corporations by the Republican-dominated Congress in December. Spoiler alert: Not workers or customers, but shareholders, especially the rich ones. (Don´t be fooled by those $1,000 bonuses...